Circulating immune complexes in rats bearing chemically induced tumors. I. Sequential determination during the growth of tumours at various body sites
- 15 April 1978
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 21 (4) , 496-504
- https://doi.org/10.1002/ijc.2910210416
Abstract
Circulating immune complexes were measured in sequential monitoring studies in rats bearing chemically induced tumours at different body sites. The assay employed were based upon radio‐immunoprecipitation of serum factors with 125I‐C1q or with an indirect test whereby the inhibition of binding of 125I‐C1q to IgG aggregates by tumour‐bearer sera was measured. 125I‐C1q‐binding immune complexes were detected at the initial phase of tumour growth and the level of this activity returned to the normal range after tumour excision. With tumours growing at subcutaneous sites or in the peritoneal cavity, serum‐borne C1q‐binding material, after reaching a maximum level, decreased despite tumour progression and eventually fell into sub‐normal ranges at terminal stages of growth. In contrast, following intravenous tumour cell injection, immune‐complex levels increased until terminal stages of disease. The present findings indicate that the measurement of C1q‐binding serum factors represents a useful method for monitoring the growth and burden of experimental animal tumours.This publication has 31 references indexed in Scilit:
- Clinical Relevance of Circulating Immune Complexes in Human LeukemiaJournal of Clinical Investigation, 1977
- Circulating immune complexes in patients with breast cancer.BMJ, 1977
- Quantitation of immune complexes by competitive inhibition of binding of Clq to insoluble IgG aggregatesJournal of Immunological Methods, 1977
- Antibody-Induced Modulation and Shedding of Mammary Tumor Virus Antigens on the Surfaces of GR Ascites Leukemia Cells as Compared With Normal Antigens2JNCI Journal of the National Cancer Institute, 1976
- FACTORS INTERFERING WITH IMMUNOLOGICAL REJECTION OF TUMOURSBritish Medical Bulletin, 1976
- Serum factor levels during the growth of rat hepatoma nodules in the lungsInternational Journal of Cancer, 1976
- Serum factors modifying cell mediated immunity to rat hepatoma D23 correlated with tumour growthInternational Journal of Cancer, 1975
- Inhibition of hepatoma‐immune lymph‐node cell cytotoxicity by tumour‐bearer serum, and solubilized hepatoma antigenInternational Journal of Cancer, 1973
- Blocking of Lymphocyte-mediated Cytotoxicity for Rat Hepatoma Cells by Tumour-specific Antigen-Antibody ComplexesNature New Biology, 1972
- Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata.British Journal of Cancer, 1967